1. Home
  2. UTHR vs CHKP Comparison

UTHR vs CHKP Comparison

Compare UTHR & CHKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$485.36

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Logo Check Point Software Technologies Ltd.

CHKP

Check Point Software Technologies Ltd.

HOLD

Current Price

$180.91

Market Cap

19.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTHR
CHKP
Founded
1996
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
19.4B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
UTHR
CHKP
Price
$485.36
$180.91
Analyst Decision
Buy
Buy
Analyst Count
12
19
Target Price
$498.83
$229.11
AVG Volume (30 Days)
343.7K
1.3M
Earning Date
02-25-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
16.08
24.68
EPS
26.38
9.12
Revenue
$3,128,400,000.00
$2,684,200,000.00
Revenue This Year
$13.57
$8.42
Revenue Next Year
$5.72
$6.11
P/E Ratio
$18.16
$19.32
Revenue Growth
13.50
6.31
52 Week Low
$266.98
$170.49
52 Week High
$519.99
$234.36

Technical Indicators

Market Signals
Indicator
UTHR
CHKP
Relative Strength Index (RSI) 54.06 42.97
Support Level $462.02 $170.49
Resistance Level $487.50 $180.00
Average True Range (ATR) 9.08 4.88
MACD 1.70 -0.27
Stochastic Oscillator 88.42 44.25

Price Performance

Historical Comparison
UTHR
CHKP

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About CHKP Check Point Software Technologies Ltd.

Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.

Share on Social Networks: